京東集團-SW(09618.HK)擬分拆京東工業於港交所主板獨立上市
格隆匯3月30日丨京東集團-SW(09618.HK)公吿,公司擬通過以京東工業股份於香港聯交所主板獨立上市的方式分拆京東工業。根據第15項應用指引,公司已就擬議分拆向香港聯交所提交分拆建議,且香港聯交所已確認公司可進行擬議分拆。
於2023年3月30日,京東工業通過其聯席保薦人向香港聯交所提交上市申請表格(表格A1),以申請京東工業股份於香港聯交所主板上市及買賣。
現建議,擬議分拆將以京東工業股份全球發售的方式進行(包括香港公開發售及國際發售)。擬議分拆完成後,公司將繼續間接持有京東工業50%以上的股權,因此,京東工業將仍為公司的子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.